Full coverage· Health· Updated
Startup Uses Personalized Scent Technology to Treat Sleep Problems
Kimba, a startup founded by Ben Foxbrunner and Gabi Beck, raised $6.5 million to market an AI sleep device that uses personalized scent therapy. The company says clinical studies showed improved sleep and cognition, and it is already selling in the U.S. with an Israel launch planned.
2 newsrooms · 1 language · since
Plus
What happened
- 01Kimba raised $6.5 million in seed funding for AI-based scent therapy.
- 02Founder Ben Foxbrunner built the product after PTSD and chronic insomnia.
- 03The system is sold in the U.S. for $299 and will soon launch in Israel.
- 04A 50-person study found 21% better cognition and 86% reported improved sleep.
- 05Two additional Israeli clinical studies are now testing the technology.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- Centre1
- RightNone
- HarediNone
- ArabNone
- Other1
How it broke
See which of the 2 newsrooms broke it, and who waited